57 participants
Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-11-20
- Start Date:
- 2017-04-13
- Completion:
- 2022-11-21
Conditions
- Breast Cancer
- Triple Negative Breast Cancer
- Luminal B
Interventions
- DRUG
No Results Yet